Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Modulation of THC Effects by CBD in Healthy Cannabis Users
NCT06099379Phase 2Recruiting
- Sponsor
- Centre hospitalier de l’Université de Montréal
- Start
- Jun 2024
- Primary completion
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, triple-blind trial of cannabidiol (5 arms), sponsored by Centre hospitalier de l’Université de Montréal. Primary endpoint: Objective and subjective measures of cannabinoids effect. Started Jun 2024; status: recruiting.
02
Drugs
cannabidiol
Beyond the preview
Go deeper on NCT06099379.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06099379.